Hypotension Prediction Index for Blood Pressure Management



Status:Recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:45 - Any
Updated:9/9/2018
Start Date:July 12, 2018
End Date:July 2020
Contact:Kamal Maheshwari, MD, MPH
Email:maheshk@ccf.org
Phone:2164454311

Use our guide to learn which trials are right for you!

The Role of Acumen Hypotension Prediction Index Software in Hypotension Management During Moderate to High-Risk Noncardiac Surgery: A Pilot Randomized Control Trial

Design: Single-center randomized comparison of invasive arterial pressure monitoring vs.
arterial pressure monitoring combined with Acumen Hypotension Prediction Index (HPI) software
guidance on intraoperative hypotension duration and severity.

Aim: To determine whether use of Acumen HPI software guidance to guide intraoperative
hemodynamic management in the non-cardiac surgery reduces the duration and severity of
hypotension.

Primary hypothesis: Our primary hypothesis is that adding Acumen HPI software guidance to the
information provided by the invasive arterial pressure monitoring during moderate- to
high-risk noncardiac surgery reduces time-weighted average (TWA) intraoperative hypotension
below a threshold of 65 mmHg.

STUDY RATIONALE Even when clinicians try to prevent intraoperative hypotension, they often
fail because it is difficult to predict which patients will become hypotensive, much less
when. A risk score for predicting minute-by-minute intraoperative hypotension is not
currently available. Yet it seems likely that ability to identify when a patient is likely to
become hypotensive, and the pathophysiology of the event, will improve hemodynamic management
and perhaps patient outcome. Acumen HPI appears to be a reliable predictor of intraoperative
hypotension, and should thus help clinicians anticipate and avoid hypotension. Furthermore,
the secondary guidance provided by the Acumen HPI may help clinicians optimally manage fluids
and thus prevent future episodes in the same patient.

AIMS To determine whether use of Acumen HPI software to guide intraoperative hemodynamic
management in the non-cardiac surgery reduces the duration and severity of hypotension.

PRIMARY HYPOTHESIS Our primary hypothesis is that use of the Acumen HPI software guidance
reduces TWA intraoperative hypotension below a threshold of 65 mmHg.

Specifically, we will compare the amount of intraoperative hypotension below mean-arterial
pressure (MAP) threshold of 65 mmHg, in patients randomized to invasive arterial pressure
monitoring vs. invasive arterial pressure monitoring with Acumen Hypotension Prediction Index
software. In both cases, clinicians will strive to keep MAP above 65 mmHg to the extent
practical.

Inclusion Criteria:

- Written informed consent

- Age ≥45 years

- ASA Physical Status 3 or 4

- Moderate- or high-risk surgery (for example, orthopedic, spine, urology, and general
surgery)

- Planned invasive blood pressure monitoring

- General anesthesia

- Surgery duration expected to last >2 hours

- Planned overnight hospitalization

Exclusion Criteria:

- Contraindication to the invasive blood pressure monitoring

- Pregnancy

- Emergency surgery

- Known clinically important intracardiac shunts

- Known aortic stenosis with valve area ≤ 1.5 cm2

- Known moderate to severe aortic regurgitation

- Known moderate to severe mitral regurgitation

- Known moderate to severe mitral stenosis

- Patient or surgical procedure type known as an SVV limitation16 (e.g. tidal volume
<8mL/kg of theoretical ideal weight, spontaneous ventilation, persistent cardiac
arrhythmia, known atrial fibrillation, open chest surgery, Heart Rate/Respiratory Rate
(HR/RR) ratio <3.6)

- Current persistent atrial fibrillation

- Congestive heart failure with ejection fraction <35%

- Neurosurgery

- Emergent or cardiovascular surgical procedure

- Patient who is confirmed to be pregnant

- Refusal of patient or authorized representative to sign consent
We found this trial at
1
site
9500 Euclid Avenue
Cleveland, Ohio 44106
216.444.2200
Principal Investigator: Kamal Maheshwari, MD MPH
Phone: 216-444-9950
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials